Press Releases

OSLO, Norway, Aug. 29, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that it will host a R&D Day in Oslo on Tuesday, 17 September 2019 from 9:30am to 12:30pm CEST. The programme will include presentations from three external experts and by Nordic Nanovecto

STOCKHOLM, Aug. 29, 2019 /PRNewswire/ -- US sales started"During the second quarter, we reached a significant milestone by recording our first IRRAflow revenue in the United States (US). The US is the world´s largest market for neurosurgical procedures, and with the ongoing CE Mark recertification process, we have

TORONTO, Aug. 29, 2019 /PRNewswire/ - VERDEMED HOLDINGS INC. ("Verdemed" or the "Company") is pleased to announce the appointment of Mr. David Beatty as a member of its Board of Directors, and Mr. Alexandre Penha as Chief Financial Officer. Mr. Beatty and Mr. Penha have extensive Canadian cap

TOKYO, Aug. 29, 2019 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President and Representative Director: Masayuki Kobayashi) announced on August 29 that the company has entered into an agreement to invest up to US$30 million in R

Financial Highlights Revenue grew significantly by 83.9% YoY from RMB77.4 million to approximately RMB142.3 million. Gross profit recorded approximately RMB71.9 million, growing significantly by 70.0% from RMB42.3 million. Net profit excluding extraordinary profit o

SINGAPORE, Aug. 28, 2019 /PRNewswire/ -- Esco Ventures is pleased to announce the launch of Carmine Therapeutics and execution of an exclusive license agreement for the technology developed in the laboratories of Professors Minh Le and Jiahai Shi at the City University of Hong Kong. Carmine Therapeutics plans

OAKLAND, Calif., Aug. 28, 2019 /PRNewswire/ -- Kaiser Permanente has demonstrated promising results in reducing secondary cardiac events and rehospitalizations by creating a virtual cardiac rehabilitation program that fits seamlessly into patients' lives. Increasing rates of program enrollment and completion have been key factors in the improved outcomes. Results a

SUZHOU, China, Aug. 28, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced its interim financial results for the six months ended June 30, 2019.HIGHLIGHTS AND OT

WASHINGTON, Aug. 28, 2019 /PRNewswire/ -- Family Research Council applauded the Department of Health and Human Services (HHS) Office for Civil Rights (OCR) for issuing a Notice of Violation against the University of Vermont Medical Center (UVMMC) for unlawfully forcing a nurse to assist in an abortion. The OCR found UVMMC's policy required em

TARRYTOWN, N.Y. and PARIS, Aug. 28, 2019 /PRNewswire/ --Court rules in favor of Regeneron and Sanofi in ongoing Praluent® (alirocumab) patent litigation